Licensing opportunities

Genmab is a leader in creating and developing differentiated antibody therapeutics and next generation antibody technologies. Partnering of our innovative product candidates and technologies is a key focus of our strategy and in recent years Genmab has entered into multiple alliances with top tier pharmaceutical and biotechnology companies. We are actively seeking new partnerships with companies who are interested in licensing our development stage product candidates or our proprietary antibody technologies. In addition, Genmab is also seeking to collaborate with other biotech or pharmaceutical companies to develop novel antibody therapeutics in a range of disease areas.